Search This Blog

Thursday, July 13, 2023

TG Therapeutics falls as Roche succeeds in Phase 3 trial for multiple sclerosis therapy

TG Therapeutics falls as Roche succeeds in Phase 3 trial for multiple sclerosis therapy



No comments:

Post a Comment

Note: Only a member of this blog may post a comment.